[
  {
    "date": "2023-12-30",
    "symbol": "RARE",
    "period": "FY",
    "netincomeloss": -606639000,
    "trdarrsecuritiesaggavailamt": 2322,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "RARE",
    "entityregistrantname": "Ultragenyx Pharmaceutical Inc.",
    "entitycentralindexkey": 1515673,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "securityexchangename": "NASDAQ",
    "security12btitle": "Common Stock, $0.001 par value",
    "entityfilenumber": "001-36276",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "27-2546083",
    "entityaddressaddressline1": "60 Leveroni Court",
    "entityaddresscityortown": "Novato",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94949,
    "cityareacode": 415,
    "localphonenumber": "483-8800",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "San Mateo, California",
    "cashandcashequivalentsatcarryingvalue": 213584000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 363625000,
    "accountsreceivablenetcurrent": 73390000,
    "inventorynet": 33969000,
    "otherassetscurrent": 47616000,
    "assetscurrent": 732184000,
    "propertyplantandequipmentnet": 290566000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 199901000,
    "intangibleassetsnetexcludinggoodwill": 166271000,
    "goodwill": 44406000,
    "otherassetsnoncurrent": 57685000,
    "assets": 1491013000,
    "accountspayablecurrent": 42114000,
    "accruedliabilitiescurrent": 196486000,
    "operatingandfinanceleaseliabilitycurrent": 12595000,
    "liabilitiesforsalesoffutureroyaltiescurrent": 29242000,
    "liabilitiescurrent": 280437000,
    "operatingandfinanceleaseliabilitynoncurrent": 30574000,
    "deferredincometaxliabilitiesnet": 30058000,
    "liabilityrelatedtosaleoffutureroyalties": 862325000,
    "otherliabilitiesnoncurrent": 12205000,
    "liabilities": 1215599000,
    "commonstockvalue": 82000,
    "treasurystockvalue": 432000,
    "treasurystockdeferredemployeestockownershipplan": 432000,
    "additionalpaidincapital": 3662346000,
    "accumulatedothercomprehensiveincomelossnetoftax": 647000,
    "retainedearningsaccumulateddeficit": -3387661000,
    "stockholdersequity": 275414000,
    "liabilitiesandstockholdersequity": 1491013000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 25000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 250000000,
    "commonstocksharesoutstanding": 82315590,
    "treasurystockcommonshares": 9559,
    "revenuefromcontractwithcustomerexcludingassessedtax": 180413000,
    "costofsales": 45209000,
    "researchanddevelopmentexpense": 648449000,
    "sellinggeneralandadministrativeexpense": 309799000,
    "costofsalesandoperatingexpenses": 1003457000,
    "operatingincomeloss": -569208000,
    "investmentincomeinterest": 26688000,
    "equitysecuritiesfvnigainloss": 397000,
    "noncashinterestexpenseonliabilityrelatedtosaleoffutureroyalties": 66004000,
    "othernonoperatingincomeexpense": -337000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -608464000,
    "incometaxexpensebenefit": -1825000,
    "earningspersharebasic": -8.25,
    "earningspersharediluted": -8.25,
    "weightedaveragenumberofsharesoutstandingbasic": 73543862,
    "weightedaveragenumberofdilutedsharesoutstanding": 73543862,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationgainlossarisingduringperiodnetoftax": 239000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 6981000,
    "othercomprehensiveincomelossnetoftax": 7220000,
    "comprehensiveincomenetoftax": -599419000,
    "prefundedwarrantsandstockissuedduringperiodvalueatunderwrittenpublicoffering": 10000,
    "stockissuedduringperiodvalueatmarketoffering": 1000,
    "prefundedwarrantsandstockissuedduringperiodsharesatunderwrittenpublicoffering": 9833334,
    "stockissuedduringperiodsharesatmarketoffering": 1175584,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 134169000,
    "issuanceofcommonstockuponexerciseofwarrantsandunderequityplanawardsnetoftax": 1000,
    "issuanceofcommonstockuponexerciseofwarrantsandunderequityplanawardsnetoftaxshares": 1109375,
    "deferredcompensation": -432000,
    "allocatedsharebasedcompensationexpensenetofcapitalizedinventorycost": 135227000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 12842000,
    "depreciationdepletionandamortization": 26006000,
    "noncashcollaborationroyaltyrevenue": 69364000,
    "othernoncashincomeexpense": -2300000,
    "increasedecreaseinaccountsreceivable": 22778000,
    "increasedecreaseininventories": 6930000,
    "increasedecreaseinotheroperatingassets": -15325000,
    "increasedecreaseinaccountspayableaccruedliabilitiesandotheroperatingliabilities": 2380000,
    "increasedecreaseincontractliabilities": -1479000,
    "increasedecreaseindeferredliabilities": -1619000,
    "netcashprovidedbyusedinoperatingactivities": -474806000,
    "paymentstoacquirepropertyplantandequipment": 44267000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 526382000,
    "proceedsfromsaleofavailableforsalesecuritiesdebt": 50672000,
    "proceedsfrommaturitiesprepaymentsandcallsofavailableforsalesecurities": 695525000,
    "paymentstoacquireintangibleassets": 2500000,
    "paymentsforproceedsfromotherinvestingactivities": 5048000,
    "netcashprovidedbyusedininvestingactivities": 168000000,
    "proceedsfromtheissuanceofcommonstockandprefundedwarrantsinconnectionwithunderwrittenpublicofferingsnetofissuancecosts": 326456000,
    "proceedsfromtheissuanceofcommonstockinconnectionwithatthemarketofferingnetofissuancescosts": 53299000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 8415000,
    "proceedsfrompaymentsforotherfinancingactivities": -28000,
    "netcashprovidedbyusedinfinancingactivities": 388142000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 462000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 81798000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 219399000,
    "operatingandfinanceleaseliabilityfromobtainingrightofuseassetsandpropertyplantandequipment": 22162000,
    "capitalexpendituresincurredbutnotyetpaid": 1577000,
    "noncashinterestexpenseonliabilityrelatedtothesaleoffutureroyaltiescapitalizedintoendingpropertyplantandequipment": 9431000,
    "numberofreportablesegments": 1,
    "restrictedcashcurrent": 2008000,
    "restrictedcashandcashequivalentscurrentassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherAssetsCurrent",
    "restrictedcashnoncurrent": 3807000,
    "restrictedcashandcashequivalentsnoncurrentassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent",
    "investmentsfairvaluedisclosure": 162289000,
    "deferredcompensationliabilitycurrentandnoncurrent": 200000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 162289000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 711000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 337000,
    "availableforsalesecuritiesdebtsecurities": 162289000,
    "availableforsalesecuritiescontractualmaturity": "P3Y",
    "depreciationexcludingintangibleamortization": 22200000,
    "inventoryworkinprocess": 18859000,
    "inventoryfinishedgoods": 15110000,
    "propertyplantandequipmentgross": 181356000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 83401000,
    "propertyplantandequipmentusefullife": "P20Y",
    "propertyplantandequipmentusefullifedescriptionoftermextensibleenumeration": "http://fasb.org/us-gaap/2023#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember",
    "researchclinicalstudyandmanufacturingexpenses": 65326000,
    "employeerelatedliabilitiescurrent": 82936000,
    "otheraccruedliabilitiescurrent": 48224000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedindefinitelivedintangibleassets": 129000000,
    "finitelivedintangibleassetsremainingamortizationperiod1": "P5Y8M12D",
    "acquiredfinitelivedintangibleassetsweightedaverageusefullife": "P10Y",
    "regulatorymilestonepaymentsachieved": 4800000,
    "finitelivedintangibleassetusefullife": "P9Y7M6D",
    "amortizationofintangibleassets": 3800000,
    "intangibleassetsgrossexcludinggoodwill": 129000000,
    "finitelivedintangibleassetsaccumulatedamortization": 7504000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 4903000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 4903000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 4903000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 4462000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 4022000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 14078000,
    "finitelivedintangibleassetsnet": 37271000,
    "salesreserves": 17029000,
    "salesreservesprovisions": 18761000,
    "salesreservespayments": 12746000,
    "salesreservesadjustments": 473000,
    "contractwithcustomerliabilitydeductionsduringperiod": 1479000,
    "percentageofgrossaccountsreceivablebalance": 0.53,
    "futurecontingentmilestonepayments": 7500000,
    "profitlosssharingpercentageonnetsales": 0.3,
    "profitlosssharingpercentageoncommercializingproducts": 0.5,
    "revenuesharepercentageoncommercializedproductsrangemidtohigh": 0.2,
    "royaltypercentageonnetsales": 0.1,
    "accountsreceivablenet": 39200000,
    "otherreceivables": 1100000,
    "accruedliabilitiescurrentandnoncurrent": 5300000,
    "milestonepaymentspaid": 100000,
    "collaborativearrangementnatureandpurpose": "The Company also has an option and license agreement with REGENX under which the Company has an exclusive, sublicensable, worldwide license to make, have made, use, import, sell, and offer for sale licensed products to treat Wilson disease and CDKL5 deficiency.",
    "licensedoptionmaintenancefee": 100000,
    "annualfeespayable": 100000,
    "contractwithcustomerliabilityrevenuerecognized": 183300000,
    "contractwithcustomerliability": 25000000,
    "collaborativearrangementtransactionstatementofincomeorcomprehensiveincomeextensibleenumeration": "http://fasb.org/us-gaap/2023#RevenueFromContractWithCustomerExcludingAssessedTax",
    "revenuefromcollaborativearrangementexcludingrevenuefromcontractwithcustomer": 125000000,
    "deferredrevenuerevenuerecognized1": 1500000,
    "developmentcosts": 7600000,
    "eligiblefuturemilestonepayments": 1000000,
    "accruedcollaborationpayables": 10600000,
    "collaborativearrangementseffectivereductionofexpenseinresearchanddevelopmentexpenses": -6510000,
    "collaborativearrangementseffectivereductionofexpenseinsellinggeneralandadministrativeexpenses": -17199000,
    "fairvalueoptionchangesinfairvaluegainloss1": 397000,
    "lesseeoperatingleaseoptiontoextend": "multiple renewal periods",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseexpiryyear": 2029,
    "operatingleaserightofuseassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent",
    "operatingleaserightofuseasset": 23900000,
    "operatingleasepayments": 13400000,
    "operatingleaseweightedaverageremainingleaseterm1": "P4Y6M",
    "operatingleaseweightedaveragediscountratepercent": 0.096,
    "operatingleasecost": 12883000,
    "variableleasecost": 5272000,
    "financeleaserightofuseassetamortization": 203000,
    "leasecost": 18358000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 16234000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 11932000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 8430000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 5867000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 5887000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 6009000,
    "lesseeoperatingleaseliabilitypaymentsdue": 54359000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 11190000,
    "operatingleaseliability": 43169000,
    "operatingleaseliabilitycurrent": 12595000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://www.ultragenyx.com/20231231#OperatingAndFinanceLeaseLiabilityCurrent",
    "operatingleaseliabilitynoncurrent": 30574000,
    "operatingleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://www.ultragenyx.com/20231231#OperatingAndFinanceLeaseLiabilityNoncurrent",
    "financeleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://www.ultragenyx.com/20231231#OperatingAndFinanceLeaseLiabilityCurrent",
    "financeleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://www.ultragenyx.com/20231231#OperatingAndFinanceLeaseLiabilityNoncurrent",
    "royaltyagreementterminationdescription": "The agreement with RPI will automatically terminate, and the payment of royalties to RPI will cease, in the event aggregate royalty payments received by RPI are equal to or greater than $608.0 million prior to December 31, 2030, or in the event aggregate royalty payments received by RPI are less than $608.0 million prior to December 31, 2030, or when aggregate royalty payments received by RPI are equal to $800.0 million.",
    "royaltyagreementterminationthresholdamount": 608000000,
    "debtinstrumentinterestrateeffectivepercentage": 0.062,
    "liabilityforsaleoffutureroyalties": 376641000,
    "royaltyrevenue": 20783000,
    "noncashinterestexpenseonliabilityforsaleoffutureroyaltiesandcapitalizedtopropertyplantandequipment": 32235000,
    "proceedsfromissuanceofcommonstockatmarketoffering": 53300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 19610125,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesavailableforgrantbeginningdate": "2015-01-01",
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesavailableforgrantendingdate": "2023-06-07",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 4900000,
    "proceedsfromstockoptionsexercised": 2700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 25.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 59700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 54600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 33000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 195462,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 219800000,
    "employeeservicesharebasedcompensationallocationofrecognizedperiodcostscapitalizedamountincludingamountexpensedtocostofgoodssold": 1900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 8787712,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 2123256,
    "stockissuedduringperiodsharesstockoptionsexercised": 209793,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 899118,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5415110,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 8461973,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 67.43,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 45.05,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 13.07,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 71.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 73.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 67.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y4M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P4Y11M15D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y3M14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 7558000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 1214000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 6794000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1380998,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 2447170,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 243601,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 67.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 44.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 67.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P3Y1M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 738130,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 73.99,
    "allocatedsharebasedcompensationexpense": 1166000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.042,
    "definedcontributionplancostrecognized": 9700000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -608166000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -298000,
    "stateandlocalincometaxexpensebenefitcontinuingoperations": -3187000,
    "foreignincometaxexpensebenefitcontinuingoperations": 3127000,
    "currentincometaxexpensebenefit": -60000,
    "deferredstateandlocalincometaxexpensebenefit": 1608000,
    "deferredforeignincometaxexpensebenefit": 157000,
    "deferredincometaxexpensebenefit": 1765000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 1004800000,
    "operatinglosscarryforwardsexpirationyear": 2031,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 46900000,
    "taxcreditcarryforwardexpirationyear": 2030,
    "deferredtaxassetsoperatinglosscarryforwards": 266253000,
    "valuationallowancedeferredtaxassetchangeinamount": 141300000,
    "incometaxreconciliationchangeinenactedtaxrate": 1300000,
    "increasedecreaseindeferredincometaxes": -1600000,
    "incometaxexaminationpenaltiesandinterestaccrued": 200000,
    "undistributedearningsofforeignsubsidiaries": 10800000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.008,
    "effectiveincometaxratereconciliationtaxcredits": -0.073,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.007,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.003,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.018,
    "effectiveincometaxratereconciliationchangeinuncertaintaxpositions": -0.014,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.241,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.005,
    "effectiveincometaxratecontinuingoperations": 0.003,
    "deferredtaxassetstaxcreditcarryforwards": 305198000,
    "deferredtaxassetsstockoption": 44795000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 27694000,
    "deferredtaxassetfixedassetsandintangibles": 33853000,
    "deferredtaxassetsliabilityrelatedtosaleoffutureroyalties": 205400000,
    "deferredtaxassetsequitymethodinvestments": 8423000,
    "deferredtaxassetsinprocessresearchanddevelopment": 149898000,
    "deferredtaxassetsother": 281000,
    "deferredtaxassetsgross": 1041795000,
    "deferredtaxassetsvaluationallowance": 1035836000,
    "deferredtaxassetsnet": 5959000,
    "deferredincometaxliabilities": 30688000,
    "deferredtaxliabilities": 30058000,
    "unrecognizedtaxbenefits": 79998000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 12562000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 642000,
    "contractualobligationmaturityperiod": "P12M",
    "contractualobligationdueinnexttwelvemonths": 27899000,
    "contractualobligationdueinsecondyear": 5718000,
    "contractualobligation": 33617000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 14152286,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": -606000,
    "accumulatedothercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 1253000
  },
  {
    "date": "2022-12-30",
    "symbol": "RARE",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "RARE",
    "entityregistrantname": "Ultragenyx Pharmaceutical Inc.",
    "entitycentralindexkey": 1515673,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "securityexchangename": "NASDAQ",
    "security12btitle": "Common Stock, $0.001 par value",
    "entityfilenumber": "001-36276",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "27-2546083",
    "entityaddressaddressline1": "60 Leveroni Court",
    "entityaddresscityortown": "Novato",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94949,
    "cityareacode": 415,
    "localphonenumber": "483-8800",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "San Mateo, California",
    "cashandcashequivalentsatcarryingvalue": 132944000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 614818000,
    "accountsreceivablenetcurrent": 40445000,
    "inventorynet": 26766000,
    "prepaidexpenseandotherassetscurrent": 68926000,
    "assetscurrent": 883899000,
    "propertyplantandequipmentnet": 259726000,
    "equityinvestmentsnoncurrent": 5531000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 148970000,
    "operatingleaserightofuseasset": 25961000,
    "intangibleassetsnetexcludinggoodwill": 160105000,
    "goodwill": 44406000,
    "otherassetsnoncurrent": 16846000,
    "assets": 1545444000,
    "accountspayablecurrent": 43274000,
    "accruedliabilitiescurrent": 204678000,
    "contractliabilitiescurrent": 1479000,
    "operatingandfinanceleaseliabilitycurrent": 11779000,
    "liabilitiescurrent": 261210000,
    "operatingandfinanceleaseliabilitynoncurrent": 19814000,
    "deferredincometaxliabilitiesnet": 31667000,
    "liabilityrelatedtosaleoffutureroyalties": 875439000,
    "otherliabilitiesnoncurrent": 4820000,
    "liabilities": 1192950000,
    "commonstockvalue": 70000,
    "additionalpaidincapital": 3140019000,
    "accumulatedothercomprehensiveincomelossnetoftax": -6573000,
    "retainedearningsaccumulateddeficit": -2781022000,
    "stockholdersequity": 352494000,
    "liabilitiesandstockholdersequity": 1545444000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 25000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 250000000,
    "commonstocksharesissued": 70197297,
    "commonstocksharesoutstanding": 70197297,
    "revenuefromcontractwithcustomerexcludingassessedtax": 222710000,
    "costofsales": 28320000,
    "researchanddevelopmentexpense": 705789000,
    "sellinggeneralandadministrativeexpense": 278139000,
    "costofsalesandoperatingexpenses": 1012248000,
    "operatingincomeloss": -648919000,
    "investmentincomeinterest": 11074000,
    "equitysecuritiesfvnigainloss": -19299000,
    "noncashinterestexpenseonliabilityrelatedtosaleoffutureroyalties": 43015000,
    "othernonoperatingincomeexpense": -1566000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -701725000,
    "incometaxexpensebenefit": 5696000,
    "netincomeloss": -707421000,
    "earningspersharebasic": -10.12,
    "earningspersharediluted": -10.12,
    "weightedaveragenumberofsharesoutstandingbasic": 69914225,
    "weightedaveragenumberofdilutedsharesoutstanding": 69914225,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationgainlossarisingduringperiodnetoftax": -724000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -4445000,
    "othercomprehensiveincomelossnetoftax": -5169000,
    "comprehensiveincomenetoftax": -712590000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 131710000,
    "issuanceofcommonstockunderequityplanawardsnetoftax": 1000,
    "issuanceofcommonstockunderequityplanawardsnetoftaxshares": 852299,
    "allocatedsharebasedcompensationexpensenetofcapitalizedinventorycost": 130377000,
    "researchanddevelopmentinprocess": 75033000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -2699000,
    "depreciationdepletionandamortization": 18220000,
    "noncashcollaborationroyaltyrevenue": 21692000,
    "othernoncashincomeexpense": 230000,
    "increasedecreaseinaccountsreceivable": 12068000,
    "increasedecreaseininventories": 9701000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -3798000,
    "increasedecreaseinaccountspayableaccruedliabilitiesandotheroperatingliabilities": 87442000,
    "increasedecreaseincontractliabilities": -7597000,
    "increasedecreaseindeferredliabilities": -1639000,
    "netcashprovidedbyusedinoperatingactivities": -380465000,
    "paymentstoacquirepropertyplantandequipment": 116123000,
    "paymentstoacquirebusinessesnetofcashacquired": 75025000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 614735000,
    "proceedsfromsaleofavailableforsalesecuritiesdebt": 84275000,
    "proceedsfromsaleofequityinvestment": 10094000,
    "proceedsfrommaturitiesprepaymentsandcallsofavailableforsalesecurities": 450706000,
    "paymentstoacquireintangibleassets": 30000000,
    "paymentsforproceedsfromotherinvestingactivities": 844000,
    "netcashprovidedbyusedininvestingactivities": -291652000,
    "proceedsfromroyaltiesreceivedfinancingactivities": 490950000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 10813000,
    "proceedsfrompaymentsforotherfinancingactivities": -555000,
    "netcashprovidedbyusedinfinancingactivities": 501208000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -1075000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -171984000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 137601000,
    "operatingandfinanceleaseliabilityfromobtainingrightofuseassets": 1168000,
    "employeeservicesharebasedcompensationallocationofrecognizedperiodcostscapitalizedamount": 2340000,
    "capitalexpendituresincurredbutnotyetpaid": 17963000,
    "noncashinterestexpenseonliabilityrelatedtothesaleoffutureroyaltiescapitalizedintoendingpropertyplantandequipment": 11380000,
    "restrictedcashcurrent": 862000,
    "restrictedcashandcashequivalentscurrentassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent",
    "restrictedcashnoncurrent": 3795000,
    "restrictedcashandcashequivalentsnoncurrentassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent",
    "stockissuedduringperiodsharesstockoptionsexercised": 130865,
    "stockissuedduringperiodsharesnewissues": 500000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentestimatedusefullives": "Not applicable",
    "investmentsfairvaluedisclosure": 102847000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 102847000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 87000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 4700000,
    "availableforsalesecuritiesdebtsecurities": 102847000,
    "availableforsalesecuritiescontractualmaturity": "P3Y",
    "depreciationexcludingintangibleamortization": 15000000,
    "inventoryworkinprocess": 17486000,
    "inventoryfinishedgoods": 9280000,
    "propertyplantandequipmentgross": 43941000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 63381000,
    "researchclinicalstudyandmanufacturingexpenses": 73558000,
    "employeerelatedliabilitiescurrent": 78938000,
    "otheraccruedliabilitiescurrent": 52182000,
    "contractualpaymentsreceived": 4800000,
    "finitelivedintangibleassetsremainingamortizationperiod1": "P5Y8M12D",
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedindefinitelivedintangibleassets": 129000000,
    "upfrontpayment": 30000000,
    "acquiredfinitelivedintangibleassetsweightedaverageusefullife": "P10Y6M",
    "amortizationofintangibleassets": 3200000,
    "intangibleassetsgrossexcludinggoodwill": 129000000,
    "finitelivedintangibleassetusefullife": "P9Y10M24D",
    "finitelivedintangibleassetsaccumulatedamortization": 3670000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 3738000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 3738000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 3738000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 3738000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 3297000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 12856000,
    "finitelivedintangibleassetsnet": 31105000,
    "salesreserves": 11487000,
    "salesreservesprovisions": 13525000,
    "salesreservespayments": 9613000,
    "salesreservesadjustments": -394000,
    "contractwithcustomerassetsliabilitycurrent": 1479000,
    "contractwithcustomerliabilityadditionsduringperiod": 89000,
    "contractwithcustomerliabilitydeductionsduringperiod": 7686000,
    "percentageofgrossaccountsreceivablebalance": 0.68,
    "exclusiveoptionssubjecttooptionexerciseperiod": "the Company made an upfront payment of $20.0 million for an exclusive option to acquire GeneTx, which was exercisable any time prior to 30 days following FDA acceptance of the IND for GTX-102.",
    "futurecontingentmilestonepayments": 7500000,
    "profitlosssharingpercentageonnetsales": 0.4,
    "profitlosssharingpercentageoncommercializingproducts": 0.5,
    "royaltypercentageonnetsales": 0.1,
    "otherreceivables": 6400000,
    "accruedliabilitiescurrentandnoncurrent": 3100000,
    "milestonepaymentspaid": 100000,
    "contingentmilestonepayment": 2500000,
    "collaborativearrangementnatureandpurpose": "The Company also has an option and license agreement with REGENX under which the Company has an exclusive, sublicensable, worldwide license to make, have made, use, import, sell, and offer for sale licensed products to treat Wilson disease and CDKL5 deficiency.",
    "licensedoptionmaintenancefee": 100000,
    "annualfeespayable": 100000,
    "contractwithcustomerliabilityrevenuerecognized": 7700000,
    "contractwithcustomerliability": 25000000,
    "revenuefromcollaborativearrangementexcludingrevenuefromcontractwithcustomer": 125000000,
    "premiumfromstockpurchaseagreement": 19700000,
    "transactionpriceoflicenseagreement": 183300000,
    "estimatedreimbursementofdeliveringlicenseandtechnologyservices": 5600000,
    "developmentcosts": 7300000,
    "accountsreceivablenet": 27500000,
    "eligiblefuturemilestonepayments": 1000,
    "developmentandtransitioncosts": 3100000,
    "numberofcommonstockheld": 500000,
    "collaborativearrangementseffectivereductionofexpenseinresearchanddevelopmentexpenses": 15974000,
    "collaborativearrangementseffectivereductionofexpenseinsellinggeneralandadministrativeexpenses": 37217000,
    "collaborativearrangementseffectivereductionofexpense": 53191000,
    "fairvalueoptionchangesinfairvaluegainloss1": -8411000,
    "fairvalueofsaleofshares": -10094000,
    "lesseeoperatingleaseoptiontoextend": "multiple renewal periods",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseexpiryyear": 2028,
    "legallybindingminimumleasepayments": 23400000,
    "fitoutcosts": 9900000,
    "operatingleasepayments": 13100000,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y3D",
    "financeleaseweightedaverageremainingleaseterm1": "P2Y9M21D",
    "operatingleaseweightedaveragediscountratepercent": 0.0672,
    "financeleaseweightedaveragediscountratepercent": 0.0513,
    "operatingleasecost": 11775000,
    "variableleasecost": 4785000,
    "financeleaserightofuseassetamortization": 343000,
    "financeleaseinterestexpense": 37000,
    "leasecost": 16940000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 13244000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 11372000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 6530000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2964000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 446000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 376000,
    "lesseeoperatingleaseliabilitypaymentsdue": 34932000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 3522000,
    "operatingleaseliability": 31410000,
    "operatingleaseliabilitycurrent": 11596000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://www.ultragenyx.com/20221231#OperatingAndFinanceLeaseLiabilityCurrent",
    "operatingleaseliabilitynoncurrent": 19814000,
    "operatingleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://www.ultragenyx.com/20221231#OperatingAndFinanceLeaseLiabilityNoncurrent",
    "financeleaseliabilitypaymentsduenexttwelvemonths": 187000,
    "financeleaseliabilitypaymentsdue": 187000,
    "financeleaseliabilityundiscountedexcessamount": 4000,
    "financeleaseliability": 183000,
    "financeleaseliabilitycurrent": 183000,
    "operatingandfinanceleaseliabilitypaymentsduenexttwelvemonths": 13431000,
    "operatingandfinanceleaseliabilitypaymentsdueyeartwo": 11372000,
    "operatingandfinanceleaseliabilitypaymentsdueyearthree": 6530000,
    "operatingandfinanceleaseliabilitypaymentsdueyearfour": 2964000,
    "operatingandfinanceleaseliabilitypaymentsdueyearfive": 446000,
    "operatingandfinanceleaseliabilitydueafteryearfive": 376000,
    "operatingandfinanceleaseliabilitypaymentsdue": 35119000,
    "operatingandfinanceleaseliabilityundiscountedexcessamount": 3526000,
    "operatingandfinanceleaseliability": 31593000,
    "financeleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://www.ultragenyx.com/20221231#OperatingAndFinanceLeaseLiabilityCurrent",
    "financeleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://www.ultragenyx.com/20221231#OperatingAndFinanceLeaseLiabilityNoncurrent",
    "proceedsfromsaleoffutureroyalties": 500000000,
    "royaltyagreementterminationdescription": "The agreement with RPI will automatically terminate, and the payment of royalties to RPI will cease, in the event aggregate royalty payments received by RPI are equal to or greater than $608.0 million prior to December 31, 2030, or in the event aggregate royalty payments received by RPI are less than $608.0 million prior to December 31, 2030, or when aggregate royalty payments received by RPI are equal to $800.0 million.",
    "royaltyagreementterminationthresholdamount": 608000000,
    "debtinstrumentinterestrateeffectivepercentage": 0.093,
    "royaltiestransactioncostsnet": 9100000,
    "liabilityforsaleoffutureroyalties": 365189000,
    "noncashinterestexpenseonliabilityforsaleoffutureroyaltiesandcapitalizedtopropertyplantandequipment": 35095000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 14211103,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesavailableforgrantbeginningdate": "2015-01-01",
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesavailableforgrantendingdate": "2024-01-01",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 2600000,
    "proceedsfromstockoptionsexercised": 6200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 34.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 58700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 47100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 37800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 112974,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 229400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M10D",
    "employeeservicesharebasedcompensationallocationofrecognizedperiodcostscapitalizedamountincludingamountexpensedtocostofgoodssold": 2200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7773367,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 2293950,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 587923,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4577580,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 7471015,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 72.56,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 64.88,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 47.7,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 84.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 70.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 72.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y1M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y6M3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 8476000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 7658000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 8371000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1624599,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1827449,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 202850,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 67.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 67.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 67.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P4Y1M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 591837,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 79.59,
    "allocatedsharebasedcompensationexpense": 902000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.02,
    "definedcontributionplancostrecognized": 9000000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -703411000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 1686000,
    "stateandlocalincometaxexpensebenefitcontinuingoperations": 6062000,
    "foreignincometaxexpensebenefitcontinuingoperations": 1274000,
    "currentincometaxexpensebenefit": 7336000,
    "deferredstateandlocalincometaxexpensebenefit": -1640000,
    "deferredincometaxexpensebenefit": -1640000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 756600000,
    "operatinglosscarryforwardsexpirationyear": 2031,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 32600000,
    "taxcreditcarryforwardexpirationyear": 2030,
    "deferredtaxassetsoperatinglosscarryforwards": 231835000,
    "valuationallowancedeferredtaxassetchangeinamount": 193800000,
    "undistributedearningsofforeignsubsidiaries": 10900000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.004,
    "effectiveincometaxratereconciliationtaxcredits": -0.059,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.001,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.006,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.012,
    "effectiveincometaxratereconciliationchangeinuncertaintaxpositions": -0.012,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.24,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.002,
    "effectiveincometaxratecontinuingoperations": -0.008,
    "deferredtaxassetstaxcreditcarryforwards": 260546000,
    "deferredtaxassetsstockoption": 39784000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 27029000,
    "deferredtaxassetfixedassetsandintangibles": 39233000,
    "deferredtaxassetsliabilityrelatedtosaleoffutureroyalties": 214900000,
    "deferredtaxassetsequitymethodinvestments": 8971000,
    "deferredtaxassetsinprocessresearchanddevelopment": 75335000,
    "deferredtaxassetsother": 3028000,
    "deferredtaxassetsgross": 900661000,
    "deferredtaxassetsvaluationallowance": 894518000,
    "deferredtaxassetsnet": 6143000,
    "deferredincometaxliabilities": 31667000,
    "deferredtaxliabilities": 31667000,
    "unrecognizedtaxbenefits": 66794000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 11316000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 377000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 259000,
    "contractualobligationmaturityperiod": "P12M",
    "contractualobligationdueinnexttwelvemonths": 22892000,
    "contractualobligationdueinsecondyear": 4467000,
    "contractualobligationdueinthirdyear": 1597000,
    "contractualobligation": 28956000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 11290935,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": -845000,
    "accumulatedothercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -5728000
  },
  {
    "date": "2021-12-30",
    "symbol": "RARE",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "RARE",
    "entityregistrantname": "Ultragenyx Pharmaceutical Inc.",
    "entitycentralindexkey": 1515673,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "securityexchangename": "NASDAQ",
    "security12btitle": "Common Stock, $0.001 par value",
    "entityfilenumber": "001-36276",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "27-2546083",
    "entityaddressaddressline1": "60 Leveroni Court",
    "entityaddresscityortown": "Novato",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94949,
    "cityareacode": 415,
    "localphonenumber": "483-8800",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Redwood City, California",
    "cashandcashequivalentsatcarryingvalue": 307584000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 432612000,
    "accountsreceivablenetcurrent": 28432000,
    "inventorynet": 16231000,
    "prepaidexpenseandotherassetscurrent": 71745000,
    "assetscurrent": 856604000,
    "propertyplantandequipmentnet": 141247000,
    "equityinvestmentsnoncurrent": 34925000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 258933000,
    "operatingleaserightofuseasset": 34936000,
    "intangibleassetsnetexcludinggoodwill": 130788000,
    "goodwill": 44406000,
    "otherassetsnoncurrent": 20558000,
    "assets": 1522397000,
    "accountspayablecurrent": 17138000,
    "accruedliabilitiescurrent": 145555000,
    "contractliabilitiescurrent": 7609000,
    "operatingandfinanceleaseliabilitycurrent": 11066000,
    "liabilitiescurrent": 181368000,
    "contractliabilitiesnoncurrent": 1467000,
    "operatingandfinanceleaseliabilitynoncurrent": 30904000,
    "deferredincometaxliabilitiesnet": 33306000,
    "liabilityrelatedtosaleoffutureroyalties": 351786000,
    "otherliabilitiesnoncurrent": 1005000,
    "liabilities": 599836000,
    "commonstockvalue": 69000,
    "additionalpaidincapital": 2997497000,
    "accumulatedothercomprehensiveincomelossnetoftax": -1404000,
    "retainedearningsaccumulateddeficit": -2073601000,
    "stockholdersequity": 922561000,
    "liabilitiesandstockholdersequity": 1522397000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 25000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 250000000,
    "commonstocksharesissued": 69344998,
    "commonstocksharesoutstanding": 69344998,
    "revenuefromcontractwithcustomerexcludingassessedtax": 256438000,
    "costofsales": 16008000,
    "researchanddevelopmentexpense": 497153000,
    "sellinggeneralandadministrativeexpense": 219982000,
    "costofsalesandoperatingexpenses": 733143000,
    "operatingincomeloss": -381737000,
    "investmentincomeinterest": 1928000,
    "equitysecuritiesfvnigainloss": -42063000,
    "noncashinterestexpenseonliabilityrelatedtosaleoffutureroyalties": 29422000,
    "othernonoperatingincomeexpense": -1687000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -452981000,
    "incometaxexpensebenefit": 1044000,
    "netincomeloss": -454025000,
    "earningspersharebasicanddiluted": -6.7,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 67795540,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationgainlossarisingduringperiodnetoftax": -550000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -1543000,
    "othercomprehensiveincomelossnetoftax": -2093000,
    "comprehensiveincomenetoftax": -456118000,
    "stockissuedduringperiodvalueatmarketoffering": 1000,
    "stockissuedduringperiodsharesatmarketoffering": 1050372,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 105260000,
    "issuanceofcommonstockunderequityplanawardsnetoftax": 1000,
    "issuanceofcommonstockunderequityplanawardsnetoftaxshares": 1476106,
    "allocatedsharebasedcompensationexpensenetofcapitalizedinventorycost": 104952000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -6606000,
    "depreciationdepletionandamortization": 13239000,
    "noncashcollaborationroyaltyrevenue": 17951000,
    "othernoncashincomeexpense": -235000,
    "increasedecreaseinaccountsreceivable": 5432000,
    "increasedecreaseininventories": 3117000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 29508000,
    "increasedecreaseinaccountspayableaccruedliabilitiesandotheroperatingliabilities": 32313000,
    "increasedecreaseincontractliabilities": -57492000,
    "netcashprovidedbyusedinoperatingactivities": -338695000,
    "paymentstoacquirepropertyplantandequipment": 73093000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 1012187000,
    "proceedsfromsaleofavailableforsalesecuritiesdebt": 92896000,
    "proceedsfromsaleofequityinvestment": 79843000,
    "proceedsfrommaturitiesprepaymentsandcallsofavailableforsalesecurities": 718111000,
    "paymentsforproceedsfromotherinvestingactivities": 942000,
    "netcashprovidedbyusedininvestingactivities": -195372000,
    "proceedsfromissuanceofcommonstockatmarketoffering": 78943000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 40101000,
    "proceedsfrompaymentsforotherfinancingactivities": -492000,
    "netcashprovidedbyusedinfinancingactivities": 118552000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -1194000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -416709000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 309585000,
    "operatingandfinanceleaseliabilityfromobtainingrightofuseassets": 3142000,
    "employeeservicesharebasedcompensationallocationofrecognizedperiodcostscapitalizedamount": 1453000,
    "capitalexpendituresincurredbutnotyetpaid": 18993000,
    "noncashinterestexpenseonliabilityrelatedtothesaleoffutureroyaltiescapitalizedintoendingpropertyplantandequipment": 4650000,
    "numberofreportablesegments": 1,
    "restrictedcashandcashequivalentscurrentassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#PrepaidExpensesAndOtherCurrentAssetsMember",
    "restrictedcashnoncurrent": 2001000,
    "restrictedcashandcashequivalentsnoncurrentassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OtherNoncurrentAssetsMember",
    "stockissuedduringperiodsharesstockoptionsexercised": 687835,
    "stockissuedduringperiodsharesnewissues": 1700000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentestimatedusefullives": "Not applicable",
    "investmentsfairvaluedisclosure": 266765000,
    "debtinstrumentfaceamount": 2400000,
    "interestreceivable": 500000,
    "fairvalueadjustmentofwarrants": 600000,
    "netcarryingvalueofinvestments": 2100000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 266765000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 3000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 979000,
    "availableforsalesecuritiesdebtsecurities": 266765000,
    "availableforsalesecuritiescontractualmaturity": "P3Y",
    "depreciationexcludingintangibleamortization": 12900000,
    "inventoryworkinprocess": 10504000,
    "inventoryfinishedgoods": 5727000,
    "propertyplantandequipmentgross": 44081000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 50038000,
    "researchclinicalstudyandmanufacturingexpenses": 40880000,
    "employeerelatedliabilitiescurrent": 62591000,
    "otheraccruedliabilitiescurrent": 42084000,
    "finitelivedintangibleassetsremainingamortizationperiod1": "P7Y",
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedindefinitelivedintangibleassets": 129000000,
    "salesreserves": 7181000,
    "salesreservesprovisions": 9586000,
    "salesreservespayments": 6120000,
    "salesreservesadjustments": 198000,
    "contractwithcustomerliabilitycurrent": 9076000,
    "contractwithcustomerliabilityadditionsduringperiod": -27504000,
    "contractwithcustomerliabilitydeductionsduringperiod": -84996000,
    "percentageofgrossaccountsreceivablebalance": 0.71,
    "profitlosssharingpercentageoncommercializingproducts": 0.5,
    "revenuesharepercentageoncommercializedproductsrangemidtohigh": 0.2,
    "royaltypercentageonnetsales": 0.1,
    "accountsreceivablenet": 20200000,
    "otherreceivables": 16000000,
    "accruedliabilitiescurrentandnoncurrent": 2300000,
    "milestonepaymentspaid": 100000,
    "futurecontingentmilestonepayments": 2500000,
    "collaborativearrangementnatureandpurpose": "The Company also has an option and license agreement with REGENX under which the Company has an exclusive, sublicensable, worldwide license to make, have made, use, import, sell, and offer for sale licensed products to treat Wilson disease and CDKL5 deficiency.",
    "licensedoptionmaintenancefee": 100000,
    "annualfeespayable": 100000,
    "milestonepaymentsreceived": 15000000,
    "contractwithcustomerliabilityrevenuerecognized": 174200000,
    "contractwithcustomerliability": 25000000,
    "exclusiveoptionssubjecttooptionexerciseperiod": "the Company made an upfront payment of $20.0 million for an exclusive option to acquire GeneTx, which was exercisable any time prior to 30 days following FDA acceptance of the IND for GTX-102.",
    "optionextensionrighttoacquiresubjecttodescription": "The Company has a right to acquire GeneTx for a payment of $125.0 million, at any time, until the earlier of 30 months from the first dosing of a patient in a planned Phase 1/2 study (subject to extensions) or 90 days after results are available from that study.",
    "businessacquisitionnumberofquartersavailableforextension": 4,
    "revenuefromcollaborativearrangementexcludingrevenuefromcontractwithcustomer": 8000000,
    "premiumfromstockpurchaseagreement": 19700000,
    "transactionpriceoflicenseagreement": 183300000,
    "revenuefromcontractwithcustomerincludingassessedtax": 8000000,
    "estimatedreimbursementofdeliveringlicenseandtechnologyservices": 5600000,
    "deferredrevenuerevenuerecognized1": 85000000,
    "receivablerelatedtolicenseagreementcurrent": 100000,
    "numberofcommonstockheld": 500000,
    "collaborativearrangementseffectivereductionofexpenseinresearchanddevelopmentexpenses": 21657000,
    "collaborativearrangementseffectivereductionofexpenseinsellinggeneralandadministrativeexpenses": 32629000,
    "collaborativearrangementseffectivereductionofexpense": 54286000,
    "fairvalueoptionchangesinfairvaluegainloss1": 2912000,
    "fairvalueofsaleofshares": -79843000,
    "lesseeoperatingleaseoptiontoextend": "multiple renewal periods",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseexpiryyear": 2028,
    "operatingleasepayments": 11800000,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y10M2D",
    "financeleaseweightedaverageremainingleaseterm1": "P3Y10M17D",
    "operatingleaseweightedaveragediscountratepercent": 0.0664,
    "financeleaseweightedaveragediscountratepercent": 0.0544,
    "operatingleasecost": 11209000,
    "variableleasecost": 4142000,
    "financeleaserightofuseassetamortization": 310000,
    "financeleaseinterestexpense": 58000,
    "leasecost": 15719000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 12873000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 13072000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 11092000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 6247000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 2681000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 776000,
    "lesseeoperatingleaseliabilitypaymentsdue": 46741000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 5749000,
    "operatingleaseliability": 40992000,
    "operatingleaseliabilitycurrent": 10498000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://www.ultragenyx.com/20211231#OperatingAndFinanceLeaseLiabilityCurrent",
    "operatingleaseliabilitynoncurrent": 30494000,
    "operatingleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://www.ultragenyx.com/20211231#OperatingAndFinanceLeaseLiabilityNoncurrent",
    "financeleaseliabilitypaymentsduenexttwelvemonths": 606000,
    "financeleaseliabilitypaymentsdueyeartwo": 349000,
    "financeleaseliabilitypaymentsdueyearthree": 75000,
    "financeleaseliabilitypaymentsdue": 1030000,
    "financeleaseliabilityundiscountedexcessamount": 52000,
    "financeleaseliability": 978000,
    "financeleaseliabilitycurrent": 568000,
    "financeleaseliabilitynoncurrent": 410000,
    "operatingandfinanceleaseliabilitypaymentsduenexttwelvemonths": 13479000,
    "operatingandfinanceleaseliabilitypaymentsdueyeartwo": 13421000,
    "operatingandfinanceleaseliabilitypaymentsdueyearthree": 11167000,
    "operatingandfinanceleaseliabilitypaymentsdueyearfour": 6247000,
    "operatingandfinanceleaseliabilitypaymentsdueyearfive": 2681000,
    "operatingandfinanceleaseliabilitydueafteryearfive": 776000,
    "operatingandfinanceleaseliabilitypaymentsdue": 47771000,
    "operatingandfinanceleaseliabilityundiscountedexcessamount": 5801000,
    "operatingandfinanceleaseliability": 41970000,
    "financeleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://www.ultragenyx.com/20211231#OperatingAndFinanceLeaseLiabilityCurrent",
    "financeleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://www.ultragenyx.com/20211231#OperatingAndFinanceLeaseLiabilityNoncurrent",
    "royaltyagreementterminationdescription": "The agreement with RPI will automatically terminate, and the payment of royalties to RPI will cease, in the event aggregate royalty payments received by RPI are equal to or greater than $608.0 million prior to December 31, 2030, or in the event aggregate royalty payments received by RPI are less than $608.0 million prior to December 31, 2030, when aggregate royalty payments received by RPI are equal to $800.0 million.",
    "debtinstrumentinterestrateeffectivepercentage": 0.096,
    "noncashinterestexpenseonliabilityrelatedtosaleoffutureroyaltiesandcapitalizedtopropertyplantandequipment": 34072000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 12462795,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesavailableforgrantbeginningdate": "2015-01-01",
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesavailableforgrantendingdate": "2024-01-01",
    "sharebasedcompensationarrangementbysharebasedpaymentawardminimumpercentageofvotingrightsofallclassesofstock": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 38300000,
    "proceedsfromstockoptionsexercised": 36600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 70.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 48100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 35500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 69900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 69738,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 200000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M29D",
    "employeeservicesharebasedcompensationallocationofrecognizedperiodcostscapitalizedamountincludingamountexpensedtocostofgoodssold": 1700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6198205,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 1217820,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 336383,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3669577,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 5951372,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 75.96,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 128.63,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 53.14,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 81.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 64.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 75.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y9M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y7M28D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y8M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 112242000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 80283000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 109665000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1672625,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 738905,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 559595,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 187852,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 87.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 122.71,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 63.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 80.55,
    "allocatedsharebasedcompensationexpense": 871000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.01,
    "definedcontributionplancostrecognized": 5500000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -455314000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 2333000,
    "stateandlocalincometaxexpensebenefitcontinuingoperations": -14000,
    "foreignincometaxexpensebenefitcontinuingoperations": 1058000,
    "currentincometaxexpensebenefit": 1044000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxcredits": -0.072,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.005,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.008,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.013,
    "effectiveincometaxratereconciliationchangeinuncertaintaxpositions": -0.014,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.279,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.001,
    "effectiveincometaxratecontinuingoperations": -0.002,
    "deferredtaxassetsoperatinglosscarryforwards": 306119000,
    "deferredtaxassetstaxcreditcarryforwards": 218131000,
    "deferredtaxassetsstockoption": 33564000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 25735000,
    "deferredtaxassetfixedassetsandintangibles": 18263000,
    "deferredtaxassetsliabilityrelatedtosaleoffutureroyalties": 90826000,
    "deferredtaxassetsequitymethodinvestments": 3912000,
    "deferredtaxassetsother": 13060000,
    "deferredtaxassetsgross": 709610000,
    "deferredtaxassetsvaluationallowance": 700669000,
    "deferredtaxassetsnet": 8941000,
    "deferredincometaxliabilities": 33306000,
    "deferredtaxliabilities": 33306000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 1085400000,
    "operatinglosscarryforwardsexpirationyear": 2031,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 22900000,
    "taxcreditcarryforwardexpirationyear": 2030,
    "valuationallowancedeferredtaxassetchangeinamount": 139500000,
    "undistributedearningsofforeignsubsidiaries": 4100000,
    "unrecognizedtaxbenefits": 55360000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 8542000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 356000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 200000,
    "contractualobligationdueinnexttwelvemonths": 19225000,
    "contractualobligationdueinsecondyear": 774000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 8214063,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": -121000,
    "accumulatedothercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -1283000
  },
  {
    "date": "2020-12-30",
    "symbol": "RARE",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "RARE",
    "entityregistrantname": "Ultragenyx Pharmaceutical Inc.",
    "entitycentralindexkey": 1515673,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "securityexchangename": "NASDAQ",
    "security12btitle": "Common Stock, $0.001 par value",
    "entityfilenumber": "001-36276",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "27-2546083",
    "entityaddressaddressline1": "60 Leveroni Court",
    "entityaddresscityortown": "Novato",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94949,
    "cityareacode": 415,
    "localphonenumber": "483-8800",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 713526000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 488007000,
    "accountsreceivablenetcurrent": 23093000,
    "inventorynet": 13048000,
    "prepaidexpenseandotherassetscurrent": 57630000,
    "assetscurrent": 1295304000,
    "propertyplantandequipmentnet": 73515000,
    "equityinvestmentsnoncurrent": 155375000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 10506000,
    "operatingleaserightofuseasset": 40524000,
    "intangibleassetsnetexcludinggoodwill": 131113000,
    "goodwill": 44406000,
    "otherassetsnoncurrent": 8812000,
    "assets": 1759555000,
    "accountspayablecurrent": 12923000,
    "accruedliabilitiescurrent": 108491000,
    "contractliabilitiescurrent": 59219000,
    "operatingandfinanceleaseliabilitycurrent": 8976000,
    "liabilitiescurrent": 189609000,
    "contractliabilitiesnoncurrent": 7349000,
    "operatingandfinanceleaseliabilitynoncurrent": 39251000,
    "deferredincometaxliabilitiesnet": 33306000,
    "liabilityrelatedtosaleoffutureroyalties": 335665000,
    "liabilities": 605180000,
    "commonstockvalue": 67000,
    "additionalpaidincapital": 2773195000,
    "accumulatedothercomprehensiveincomelossnetoftax": 689000,
    "retainedearningsaccumulateddeficit": -1619576000,
    "stockholdersequity": 1154375000,
    "liabilitiesandstockholdersequity": 1759555000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 25000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 250000000,
    "commonstocksharesissued": 66818520,
    "commonstocksharesoutstanding": 66818520,
    "revenuefromcontractwithcustomerexcludingassessedtax": 219315000,
    "costofsales": 6129000,
    "researchanddevelopmentexpense": 412084000,
    "sellinggeneralandadministrativeexpense": 182933000,
    "operatingexpenses": 601146000,
    "operatingincomeloss": -330116000,
    "investmentincomeinterest": 7038000,
    "equitysecuritiesfvnigainloss": 170403000,
    "noncashinterestexpenseonliabilityrelatedtosaleoffutureroyalties": 33291000,
    "othernonoperatingincomeexpense": 607000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -185359000,
    "incometaxexpensebenefit": 1207000,
    "netincomeloss": -186566000,
    "earningspersharebasicanddiluted": -3.07,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 60845550,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationgainlossarisingduringperiodnetoftax": 735000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 101000,
    "othercomprehensiveincomelossnetoftax": 836000,
    "comprehensiveincomenetoftax": -185730000,
    "stockissuedduringperiodvaluesecondaryissues": 5000,
    "stockissuedduringperiodsharessecondaryissues": 5111110,
    "issuanceofcommonstockvalueinconnectionwithlicenseagreement": 1000,
    "issuanceofcommonstockinconnectionwithlicenseagreementnetofissuancecostsshares": 1243913,
    "stockissuedduringperiodvalueatmarketoffering": 20391000,
    "stockissuedduringperiodsharesatmarketoffering": 283333,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 85833000,
    "issuanceofcommonstockuponexerciseofwarrantsandunderequityplanawardsnetoftax": 3000,
    "issuanceofcommonstockuponexerciseofwarrantsandunderequityplanawardsnetoftaxshares": 2341944,
    "profitloss": -186566000,
    "allocatedsharebasedcompensationexpensenetofcapitalizedinventorycost": 85735000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -848000,
    "depreciationdepletionandamortization": 12261000,
    "foreigncurrencytransactiongainlossbeforetax": 221000,
    "noncashcollaborationroyaltyrevenue": 12995000,
    "othernoncashincomeexpense": -1167000,
    "increasedecreaseinaccountsreceivable": -9840000,
    "increasedecreaseininventories": 1346000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -2748000,
    "increasedecreaseinaccountspayableaccruedliabilitiesandotheroperatingliabilities": 26853000,
    "increasedecreaseincontractliabilities": 66568000,
    "netcashprovidedbyusedinoperatingactivities": -132220000,
    "paymentstoacquirepropertyplantandequipment": 43905000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 813237000,
    "paymentstoacquireequitymethodinvestments": 37062000,
    "proceedsfromsaleofavailableforsalesecuritiesdebt": 50990000,
    "proceedsfromsaleofequityinvestment": 79842000,
    "proceedsfrommaturitiesprepaymentsandcallsofavailableforsalesecurities": 589806000,
    "paymentsforproceedsfromotherinvestingactivities": 5555000,
    "netcashprovidedbyusedininvestingactivities": -179121000,
    "proceedsfromissuanceofcommonstock": 435556000,
    "proceedsfromissuanceofcommonstockinconnectionwithlicenseagreement": 55268000,
    "proceedsfromissuanceofcommonstockatmarketoffering": 20391000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 89293000,
    "proceedsfrompaymentsforotherfinancingactivities": -236000,
    "netcashprovidedbyusedinfinancingactivities": 600272000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 1119000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 290050000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 726294000,
    "operatingandfinanceleaseliabilityfromobtainingrightofuseassets": 18775000,
    "employeeservicesharebasedcompensationallocationofrecognizedperiodcostscapitalizedamount": 1304000,
    "capitalexpendituresincurredbutnotyetpaid": 8515000,
    "numberofreportablesegments": 1,
    "restrictedcashcurrent": 10847000,
    "restrictedcashandcashequivalentscurrentassetstatementoffinancialpositionextensiblelist": "us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember",
    "restrictedcashnoncurrent": 1921000,
    "restrictedcashandcashequivalentsnoncurrentassetstatementoffinancialpositionextensiblelist": "us-gaap:OtherNoncurrentAssetsMember",
    "stockissuedduringperiodsharesstockoptionsexercised": 1505486,
    "stockissuedduringperiodsharesnewissues": 283333,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Not applicable",
    "investmentsfairvaluedisclosure": 598392000,
    "investmentownedatfairvalue": 1400000,
    "debtinstrumentfaceamount": 2100000,
    "interestreceivable": 200000,
    "fairvalueadjustmentofwarrants": 600000,
    "availableforsalesecuritiesamortizedcost": 598392000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedgainbeforetax": 209000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedlossbeforetax": 17000,
    "availableforsalesecurities": 598392000,
    "availableforsalesecuritiescontractualmaturity": "P2Y",
    "depreciationexcludingintangibleamortization": 12100000,
    "inventoryworkinprocess": 7184000,
    "inventoryfinishedgoods": 5864000,
    "propertyplantandequipmentgross": 39356000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 37392000,
    "researchclinicalstudyandmanufacturingexpenses": 25875000,
    "employeerelatedliabilitiescurrent": 58176000,
    "otheraccruedliabilitiescurrent": 24440000,
    "finitelivedintangibleassetsremainingamortizationperiod1": "P7Y",
    "salesreserves": 3913000,
    "salesreservesprovisions": 5763000,
    "salesreservespayments": 2785000,
    "salesreservesadjustments": 883000,
    "contractwithcustomerliabilitycurrent": 66568000,
    "contractwithcustomerliabilityadditionsduringperiod": -155788000,
    "contractwithcustomerliabilitydeductionsduringperiod": -89220000,
    "percentageofgrossaccountsreceivablebalance": 0.71,
    "percentageofcostfordevelopingactivities": 1,
    "profitlosssharingpercentageoncommercializingproducts": 0.5,
    "revenuesharepercentageoncommercializedproductsrangemidtohigh": 0.2,
    "royaltypercentageonnetsales": 0.1,
    "accountsreceivablenet": 16400000,
    "otherreceivables": 9600000,
    "accruedliabilitiescurrentandnoncurrent": 2400000,
    "milestonepaymentspaid": 100000,
    "contingentmilestonepayment": 2000000,
    "futurecontingentmilestonepayments": 2500000,
    "collaborativearrangementnatureandpurpose": "The Company also has an option and license agreement with REGENX under which the Company has an exclusive, sublicensable, worldwide license to make, have made, use, import, sell, and offer for sale licensed products to treat Wilson disease and CDKL5 deficiency.",
    "licensedoptionmaintenancefee": 100000,
    "annualfeespayable": 100000,
    "milestonepaymentsreceived": 15000000,
    "amortizationcompletionyear": 2019,
    "contractwithcustomerliability": 25000000,
    "businesscombinationconsiderationtransferred1": 40000000,
    "remainingbusinesscombinationconsiderationtransferred1": 13200000,
    "exclusiveoptionssubjecttooptionexerciseperiod": "the Company made an upfront payment of $20.0 million for an exclusive option to acquire GeneTx, which was exercisable any time prior to 30 days following FDA acceptance of the IND for GTX-102.",
    "optionextensionrighttoacquiresubjecttodescription": "The Company has a right to acquire GeneTx for a payment of $125.0 million, at any time, until the earlier of 30 months from the first dosing of a patient in a planned Phase 1/2 study (subject to extensions) or 90 days after results are available from that study.",
    "businessacquisitionnumberofquartersavailableforextension": 4,
    "revenuefromcollaborativearrangementexcludingrevenuefromcontractwithcustomer": 125000000,
    "sharesissuedpricepershare": 44.43,
    "premiumfromstockpurchaseagreement": 19700000,
    "transactionpriceoflicenseagreement": 183700000,
    "revenuefromcontractwithcustomerincludingassessedtax": 8000000,
    "estimatedreimbursementofdeliveringlicenseandtechnologyservices": 6000000,
    "deferredrevenuerevenuerecognized1": 89200000,
    "receivablerelatedtolicenseagreementcurrent": 1200000,
    "collaborativearrangementseffectivereductionofexpenseinresearchanddevelopmentexpenses": 21476000,
    "collaborativearrangementseffectivereductionofexpenseinsellinggeneralandadministrativeexpenses": 25186000,
    "collaborativearrangementseffectivereductionofexpense": 46662000,
    "fairvalueoptionchangesinfairvaluegainloss1": 113978000,
    "transferoffairvalueonexerciseofoptions": 35212000,
    "fairvalueofsaleofshares": -79842000,
    "changeinfairvalueofadditionalcommonstock": 23948000,
    "transferoffairvalueonadditionalexerciseofoptions": -25612000,
    "lesseeoperatingleaseoptiontoextend": "multiple renewal periods",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseexpiryyear": 2028,
    "operatingleasepayments": 10300000,
    "operatingleaseweightedaverageremainingleaseterm1": "P4Y9M25D",
    "financeleaseweightedaverageremainingleaseterm1": "P4Y6M3D",
    "operatingleaseweightedaveragediscountratepercent": 0.067,
    "financeleaseweightedaveragediscountratepercent": 0.0558,
    "operatingleasecost": 10164000,
    "variableleasecost": 3298000,
    "financeleaserightofuseassetamortization": 158000,
    "financeleaseinterestexpense": 40000,
    "leasecost": 13660000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 11418000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 11904000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 12148000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 10319000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 6247000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 3456000,
    "lesseeoperatingleaseliabilitypaymentsdue": 55492000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 8426000,
    "operatingleaseliability": 47066000,
    "operatingleaseliabilitystatementoffinancialpositionextensiblelist": "rare:OperatingLeaseLiabilityMember",
    "operatingleaseliabilitycurrent": 8516000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "rare:OperatingLeaseLiabilityCurrentMember",
    "operatingleaseliabilitynoncurrent": 38550000,
    "operatingleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "rare:OperatingLeaseLiabilityNoncurrentMember",
    "financeleaseliabilitypaymentsduenexttwelvemonths": 513000,
    "financeleaseliabilitypaymentsdueyeartwo": 495000,
    "financeleaseliabilitypaymentsdueyearthree": 237000,
    "financeleaseliabilitypaymentsdue": 1245000,
    "financeleaseliabilityundiscountedexcessamount": 84000,
    "financeleaseliability": 1161000,
    "financeleaseliabilitycurrent": 460000,
    "financeleaseliabilitynoncurrent": 701000,
    "operatingandfinanceleaseliabilitypaymentsduenexttwelvemonths": 11931000,
    "operatingandfinanceleaseliabilitypaymentsdueyeartwo": 12399000,
    "operatingandfinanceleaseliabilitypaymentsdueyearthree": 12385000,
    "operatingandfinanceleaseliabilitypaymentsdueyearfour": 10319000,
    "operatingandfinanceleaseliabilitypaymentsdueyearfive": 6247000,
    "operatingandfinanceleaseliabilitydueafteryearfive": 3456000,
    "operatingandfinanceleaseliabilitypaymentsdue": 56737000,
    "operatingandfinanceleaseliabilityundiscountedexcessamount": 8510000,
    "operatingandfinanceleaseliability": 48227000,
    "royaltyagreementterminationdescription": "The agreement with RPI will automatically terminate, and the payment of royalties to RPI will cease, in the event aggregate royalty payments received by RPI are equal to or greater than $608.0 million prior to December 31, 2030, or in the event aggregate royalty payments received by RPI are less than $608.0 million prior to December 31, 2030, when aggregate royalty payments received by RPI are equal to $800.0 million.",
    "debtinstrumentinterestrateeffectivepercentage": 0.098,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 10878499,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesavailableforgrantbeginningdate": "2015-01-01",
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesavailableforgrantendingdate": "2024-01-01",
    "sharebasedcompensationarrangementbysharebasedpaymentawardminimumpercentageofvotingrightsofallclassesofstock": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 56900000,
    "proceedsfromstockoptionsexercised": 88100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 35.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 45400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 27200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 29500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 112857,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 155600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y5M23D",
    "employeeservicesharebasedcompensationallocationofrecognizedperiodcostscapitalizedamountincludingamountexpensedtocostofgoodssold": 1200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6004603,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 1849106,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 452081,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2989891,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 5699638,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 62.99,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 62.51,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 58.51,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 69.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 64.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 62.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y2M15D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y8M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y1M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 453253000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 221488000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 430243000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1681167,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 967310,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 434153,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 150140,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 63.21,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 64.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 62.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 61.42,
    "allocatedsharebasedcompensationexpense": 827000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.008,
    "definedcontributionplancostrecognized": 4300000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -189449000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 4090000,
    "stateandlocalincometaxexpensebenefitcontinuingoperations": 15000,
    "foreignincometaxexpensebenefitcontinuingoperations": 1192000,
    "currentincometaxexpensebenefit": 1207000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxcredits": -0.137,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.005,
    "effectiveincometaxratereconciliationequityinearningslossesofunconsolidatedsubsidiary": 0.022,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.009,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.009,
    "effectiveincometaxratereconciliationchangeinuncertaintaxpositions": -0.027,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.339,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.005,
    "effectiveincometaxratecontinuingoperations": -0.007,
    "deferredtaxassetsoperatinglosscarryforwards": 222902000,
    "deferredtaxassetstaxcreditcarryforwards": 184961000,
    "deferredtaxassetsstockoption": 39154000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 24922000,
    "deferredtaxassetfixedassetsandintangibles": 7242000,
    "deferredtaxassetsliabilityrelatedtosaleoffutureroyalties": 86664000,
    "deferredtaxassetsother": 28642000,
    "deferredtaxassetsgross": 594487000,
    "deferredtaxassetsvaluationallowance": 561139000,
    "deferredtaxassetsnet": 33348000,
    "deferredincometaxliabilities": 33306000,
    "deferredtaxliabilities": 33306000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 750200000,
    "operatinglosscarryforwardsexpirationyear": 2032,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 17700000,
    "taxcreditcarryforwardexpirationyear": 2030,
    "valuationallowancedeferredtaxassetchangeinamount": 74300000,
    "undistributedearningsofforeignsubsidiaries": 6300000,
    "unrecognizedtaxbenefits": 46662000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 6950000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 382000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 624000,
    "contractualobligationdueinnexttwelvemonths": 4330000,
    "contractualobligationdueinsecondyear": 472000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 8532236,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": 429000,
    "accumulatedothercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 260000
  },
  {
    "date": "2019-12-30",
    "symbol": "RARE",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "RARE",
    "entityregistrantname": "Ultragenyx Pharmaceutical Inc.",
    "entitycentralindexkey": 1515673,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "securityexchangename": "NASDAQ",
    "security12btitle": "Common Stock, $0.001 par value",
    "entityfilenumber": "001-36276",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "27-2546083",
    "entityaddressaddressline1": "60 Leveroni Court",
    "entityaddresscityortown": "Novato",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94949,
    "cityareacode": 415,
    "localphonenumber": "483-8800",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 433584000,
    "shortterminvestments": 321646000,
    "accountsreceivablenetcurrent": 32844000,
    "inventorynet": 11546000,
    "prepaidexpenseandotherassetscurrent": 51397000,
    "assetscurrent": 851017000,
    "propertyplantandequipmentnet": 44348000,
    "investmentinequitysecurities": 27752000,
    "intangibleassetsnetexcludinggoodwill": 129000000,
    "goodwill": 44406000,
    "operatingleaserightofuseasset": 30328000,
    "longterminvestments": 5174000,
    "otherassetsnoncurrent": 3471000,
    "assets": 1135496000,
    "accountspayablecurrent": 12871000,
    "accruedliabilitiescurrent": 83194000,
    "operatingleaseliabilitycurrent": 7235000,
    "liabilitiescurrent": 103300000,
    "deferredtaxliabilitiesnoncurrent": 33306000,
    "operatingleaseliabilitynoncurrent": 29757000,
    "liabilityrelatedtosaleoffutureroyalties": 315369000,
    "liabilities": 481732000,
    "commonstockvalue": 58000,
    "additionalpaidincapital": 2086863000,
    "accumulatedothercomprehensiveincomelossnetoftax": -147000,
    "retainedearningsaccumulateddeficit": -1433010000,
    "stockholdersequity": 653764000,
    "liabilitiesandstockholdersequity": 1135496000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 25000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 250000000,
    "commonstocksharesissued": 57838220,
    "commonstocksharesoutstanding": 57838220,
    "revenuefromcontractwithcustomerexcludingassessedtax": 83493000,
    "costofsales": 9008000,
    "researchanddevelopmentexpense": 357355000,
    "sellinggeneralandadministrativeexpense": 161524000,
    "operatingexpenses": 527887000,
    "operatingincomeloss": -424173000,
    "investmentincomeinterest": 13238000,
    "equitysecuritiesfvnigainloss": 13413000,
    "noncashinterestexpenseonliabilityrelatedtosaleoffutureroyalties": 1135000,
    "othernonoperatingincomeexpense": -787000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -399444000,
    "incometaxexpensebenefit": 3283000,
    "netincomeloss": -402727000,
    "earningspersharebasicanddiluted": -7.12,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 56576885,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationgainlossarisingduringperiodnetoftax": 23000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 463000,
    "othercomprehensiveincomelossnetoftax": 486000,
    "comprehensiveincomenetoftax": -402241000,
    "stockissuedduringperiodvaluesecondaryissues": 6000,
    "stockissuedduringperiodsharessecondaryissues": 5833333,
    "stockissuedduringperiodvalueatmarketoffering": 24828000,
    "stockissuedduringperiodsharesatmarketoffering": 468685,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 82025000,
    "issuanceofcommonstockunderequityplanawardsnetoftax": 1000,
    "issuanceofcommonstockunderequityplanawardsnetoftaxshares": 675614,
    "profitloss": -402727000,
    "allocatedsharebasedcompensationexpense": 81995000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 6214000,
    "depreciationdepletionandamortization": 8539000,
    "foreigncurrencytransactiongainlossbeforetax": -688000,
    "othernoncashincomeexpense": -557000,
    "increasedecreaseinaccountsreceivable": 20104000,
    "increasedecreaseininventories": 4451000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 8216000,
    "increasedecreaseinrightofuseassets": 14176000,
    "increasedecreaseinaccountspayableaccruedliabilitiesandotheroperatingliabilities": 13312000,
    "increasedecreaseinleaseliabilities": 15552000,
    "increasedecreaseindeferredliabilities": 2140000,
    "netcashprovidedbyusedinoperatingactivities": -345383000,
    "paymentstoacquirepropertyplantandequipment": 24832000,
    "paymentstoacquireavailableforsalesecurities": 692824000,
    "paymentstoacquireequitymethodinvestments": 14339000,
    "proceedsfromsaleofavailableforsalesecurities": 42718000,
    "proceedsfrommaturitiesprepaymentsandcallsofavailableforsalesecurities": 676238000,
    "netcashprovidedbyusedininvestingactivities": -13039000,
    "proceedsfromroyaltiesreceivedfinancingactivities": 314234000,
    "proceedsfromissuanceofcommonstock": 330415000,
    "proceedsfromissuanceofcommonstockatmarketoffering": 24828000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 9829000,
    "netcashprovidedbyusedinfinancingactivities": 679306000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -165000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 320719000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 436244000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 21861000,
    "employeeservicesharebasedcompensationallocationofrecognizedperiodcostscapitalizedamount": 1206000,
    "capitalexpendituresincurredbutnotyetpaid": 10367000,
    "numberofreportablesegments": 1,
    "restrictedcashcurrent": 161000,
    "restrictedcashandcashequivalentscurrentassetstatementoffinancialpositionextensiblelist": "us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember",
    "restrictedcashnoncurrent": 2499000,
    "restrictedcashandcashequivalentsnoncurrentassetstatementoffinancialpositionextensiblelist": "us-gaap:OtherNoncurrentAssetsMember",
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Shorter of lease term or estimated useful life",
    "increasedecreaseindeferredincometaxes": 33300000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "fairvalueoptionchangesinfairvaluegainloss1": 12200000,
    "changeinfairvalueofadditionalcommonstock": 1200000,
    "investmentsfairvaluedisclosure": 293309000,
    "availableforsalesecuritiesamortizedcost": 293309000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedgainbeforetax": 17000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedlossbeforetax": 13000,
    "availableforsalesecurities": 293309000,
    "availableforsalesecuritiescontractualmaturity": "P2Y",
    "depreciationexcludingintangibleamortization": 8300000,
    "inventoryworkinprocess": 8191000,
    "inventoryfinishedgoods": 3355000,
    "propertyplantandequipmentgross": 16871000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 25988000,
    "researchclinicalstudyandmanufacturingexpenses": 22894000,
    "employeerelatedliabilitiescurrent": 41324000,
    "otheraccruedliabilitiescurrent": 18976000,
    "salesreserves": 1818000,
    "salesreservesprovisions": 3846000,
    "salesreservespaymentsandadjustments": 3268000,
    "contractwithcustomerliabilityadditionsduringperiod": 504000,
    "contractwithcustomerliabilitydeductionsduringperiod": 3483000,
    "percentageofgrossaccountsreceivablebalance": 0.87,
    "profitlosssharingpercentageoncommercializingproducts": 0.5,
    "revenuesharepercentageoncommercializedproductsrangemidtohigh": 0.2,
    "royaltypercentageonnetsales": 0.1,
    "accountsreceivablenet": 28500000,
    "otherreceivables": 17800000,
    "accruedliabilitiescurrentandnoncurrent": 900000,
    "milestonepaymentspaid": 100000,
    "futurecontingentmilestonepayments": 5300000,
    "numberofdiseaseindicationoptionlicensed": 3,
    "licensedoptionmaintenancefee": 100000,
    "milestonepaymentsreceived": 15000000,
    "amortizationcompletionyear": 2019,
    "exclusiveoptionssubjecttooptionexerciseperiod": "This option may be exercised any time prior to 30 days following notice of FDA acceptance of the IND for GTX-102 for an additional $50.0 million in payments.",
    "optionextensionrighttoacquiresubjecttodescription": "In the event the Company exercises the option extension, the Company has a right to acquire GeneTx for a payment of $125.0 million, at any time, until the earlier of 30 months from the first dosing of a patient in a planned Phase 1/2 study (subject to extensions) or 90 days after results are available from that study.",
    "businessacquisitionnumberofquartersavailableforextension": 4,
    "collaborativearrangementseffectivereductionofexpenseinresearchanddevelopmentexpenses": 27309000,
    "collaborativearrangementseffectivereductionofexpenseinsellinggeneralandadministrativeexpenses": 21828000,
    "collaborativearrangementseffectivereductionofexpense": 49137000,
    "acquisitionofinvestmentincommonstock": 13872000,
    "optiontopurchaseadditionalcommonstockvalue": 1664000,
    "acquisitionofinvestmentinadditionalcommonstock": 467000,
    "lesseeoperatingleaseoptiontoextend": "multiple renewal periods",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseexpiryyear": 2028,
    "operatingleasepayments": 9000000,
    "operatingleaseweightedaverageremainingleaseterm1": "P5Y7M20D",
    "operatingleaseweightedaveragediscountratepercent": 0.075,
    "operatingleasecost": 9163000,
    "variableleasecost": 2779000,
    "leasecost": 11942000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 9786000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 7667000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 7521000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 7541000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 5571000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 7582000,
    "lesseeoperatingleaseliabilitypaymentsdue": 45668000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 8676000,
    "operatingleaseliability": 36992000,
    "royaltyagreementterminationdescription": "The agreement with RPI will automatically terminate, and the payment of royalties to RPI will cease, in the event aggregate royalty payments received by RPI are equal to or greater than $608.0 million prior to December 31, 2030, or in the event aggregate royalty payments received by RPI are less than $608.0 million prior to December 31, 2030, when aggregate royalty payments received by RPI are equal to $800.0 million.",
    "royaltyagreementterminationthresholdamount": 608000000,
    "debtinstrumentinterestrateeffectivepercentage": 0.101,
    "proceedsfromroyaltiesreceived": 314234000,
    "stockissuedduringperiodsharesnewissues": 468685,
    "classofwarrantorrightoutstanding": 149700,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 3.01,
    "classofwarrantorrightexpirationyear": 2020,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 10521371,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesavailableforgrantbeginningdate": "2015-01-01",
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesavailableforgrantendingdate": "2024-01-01",
    "sharebasedcompensationarrangementbysharebasedpaymentawardminimumpercentageofvotingrightsofallclassesofstock": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 6500000,
    "proceedsfromstockoptionsexercised": 7700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 37.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 45300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 313682,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 20800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 18400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 85845,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 133000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y4M24D",
    "employeeservicesharebasedcompensationallocationofrecognizedperiodcostscapitalizedamountincludingamountexpensedtocostofgoodssold": 1400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6113064,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 1762075,
    "stockissuedduringperiodsharesstockoptionsexercised": 235678,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 766457,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3429579,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 5847778,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 62.51,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 63.03,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 32.87,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 72.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 63.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 62.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y9M29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y11M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1298150,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 863065,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 205310,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 61.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 62.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 66.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 64.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y2M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.024,
    "definedcontributionplancostrecognized": 3600000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -399709000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 265000,
    "stateandlocalincometaxexpensebenefitcontinuingoperations": 51000,
    "foreignincometaxexpensebenefitcontinuingoperations": 1092000,
    "currentincometaxexpensebenefit": 1143000,
    "deferredstateandlocalincometaxexpensebenefit": 2140000,
    "deferredincometaxexpensebenefit": 2140000,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.005,
    "effectiveincometaxratereconciliationtaxcredits": -0.052,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.002,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.004,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.01,
    "effectiveincometaxratereconciliationchangeinuncertaintaxpositions": -0.01,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.236,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.003,
    "effectiveincometaxratecontinuingoperations": -0.008,
    "deferredtaxassetsoperatinglosscarryforwards": 185892000,
    "deferredtaxassetstaxcreditcarryforwards": 158791000,
    "deferredtaxassetsstockoption": 40676000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 19622000,
    "deferredtaxassetfixedassetsandintangibles": 3870000,
    "deferredtaxassetsliabilityrelatedtosaleoffutureroyalties": 81424000,
    "deferredtaxassetsother": 4183000,
    "deferredtaxassetsgross": 494458000,
    "deferredtaxassetsvaluationallowance": 486796000,
    "deferredtaxassetsnet": 7662000,
    "deferredincometaxliabilities": 33306000,
    "deferredtaxassetsliabilitiesnet": 33306000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 549900000,
    "operatinglosscarryforwardsexpirationyear": 2032,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 11700000,
    "taxcreditcarryforwardexpirationyear": 2030,
    "valuationallowancedeferredtaxassetchangeinamount": 125100000,
    "undistributedearningsofforeignsubsidiaries": 2100000,
    "unrecognizedtaxbenefits": 39954000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 5575000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 652000,
    "contractualobligationdueinnexttwelvemonths": 7854000,
    "contractualobligationdueinsecondyear": 461000,
    "contractualobligation": 8315000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7978666,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": -306000,
    "accumulatedothercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 159000
  }
]